BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31745664)

  • 1. Carcinoid Heart Disease: a Comprehensive Review.
    Hassan SA; Palaskas NL; Agha AM; Iliescu C; Lopez-Mattei J; Chen C; Zheng H; Yusuf SW
    Curr Cardiol Rep; 2019 Nov; 21(11):140. PubMed ID: 31745664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoid Heart Disease: A Review.
    Hayes AR; Davar J; Caplin ME
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):671-682. PubMed ID: 30098723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing carcinoid heart disease in patients with neuroendocrine tumors.
    Koffas A; Toumpanakis C
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):187-192. PubMed ID: 33321109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid heart disease in patients with midgut neuroendocrine tumours.
    Delhomme C; Walter T; Arangalage D; Suc G; Hentic O; Cachier A; Alkhoder S; François L; Lombard-Bohas C; Iung B; Ruszniewski P; de Mestier L
    J Neuroendocrinol; 2023 Apr; 35(4):e13262. PubMed ID: 37005217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement.
    Davar J; Connolly HM; Caplin ME; Pavel M; Zacks J; Bhattacharyya S; Cuthbertson DJ; Dobson R; Grozinsky-Glasberg S; Steeds RP; Dreyfus G; Pellikka PA; Toumpanakis C
    J Am Coll Cardiol; 2017 Mar; 69(10):1288-1304. PubMed ID: 28279296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland.
    Dobson R; Valle JW; Burgess MI; Poston GJ; Cuthbertson DJ
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):741-6. PubMed ID: 26170123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
    Das S; Stockton SS; Hassan SA
    Oncologist; 2023 Jul; 28(7):575-583. PubMed ID: 37209415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoid Heart Disease: a Review.
    Laskaratos FM; Davar J; Toumpanakis C
    Curr Oncol Rep; 2021 Mar; 23(4):48. PubMed ID: 33725214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do we know about carcinoid heart disease in the present era?
    Pęczkowska M; Konsek-Komorowska SJ; Kolasińska-Ćwikła AD; Konka M; Michałowska I; Ćwikła JB
    Kardiol Pol; 2022; 80(10):990-1001. PubMed ID: 36136036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoid heart disease--a hidden complication of neuroendocrine tumours.
    Dero I; De Pauw M; Borbath I; Delaunoit T; Demetter P; Demolin G; Hendlisz A; Pattyn P; Pauwels S; Roeyen G; Van Cutsem E; Van Hootegem P; Van Laethem JL; Verslype C; Peeters M
    Acta Gastroenterol Belg; 2009; 72(1):34-8. PubMed ID: 19402369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoid Heart Disease: Review of Current Knowledge.
    Ram P; Penalver JL; Lo KBU; Rangaswami J; Pressman GS
    Tex Heart Inst J; 2019 Feb; 46(1):21-27. PubMed ID: 30833833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in carcinoid heart disease - the heart of the matter.
    Oleinikov K; Korach A; Planer D; Gilon D; Grozinsky-Glasberg S
    Rev Endocr Metab Disord; 2021 Sep; 22(3):553-561. PubMed ID: 33443717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).
    Hofland J; Lamarca A; Steeds R; Toumpanakis C; Srirajaskanthan R; Riechelmann R; Panzuto F; Frilling A; Denecke T; Christ E; Grozinsky-Glasberg S; Davar J;
    J Neuroendocrinol; 2022 Mar; 34(3):e13060. PubMed ID: 34825753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of carcinoid heart disease: Seeking therapeutic targets in the era of targeted therapy.
    Khan SA; Devkota D; Chaudhary RK; Luitel A; Parajuli SB; Bista M; Rayamajhi A
    Medicine (Baltimore); 2023 Nov; 102(47):e36043. PubMed ID: 38013349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoid syndroma - diagnosis and management.
    Kiňová S; Koreň M
    Vnitr Lek; 2021; 67(5):310-314. PubMed ID: 35459398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinoid heart disease].
    Bencze A; Szücs N; Igaz P; Leiszter K; Nagy Z; Patócs A; Rácz K
    Orv Hetil; 2013 Apr; 154(14):546-50. PubMed ID: 23545233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoid syndrome: update on the pathophysiology and treatment.
    Rubin de Celis Ferrari AC; Glasberg J; Riechelmann RP
    Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e490s. PubMed ID: 30133565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort.
    Grundmann E; Curioni-Fontecedro A; Christ E; Siebenhüner AR
    BMC Cancer; 2023 Apr; 23(1):338. PubMed ID: 37055717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiography in functional midgut neuroendocrine tumors: When and how often.
    Castillo JG; Naib T; Zacks JS; Adams DH
    Rev Endocr Metab Disord; 2017 Dec; 18(4):411-421. PubMed ID: 29080935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoid Heart Disease: A Guide for Clinicians.
    Perry D; Hayek SS
    Cardiol Clin; 2019 Nov; 37(4):497-503. PubMed ID: 31587790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.